{"id":18995,"date":"2026-06-24T09:34:48","date_gmt":"2026-06-24T09:34:48","guid":{"rendered":"https:\/\/www.simpleonlinepharmacy.co.uk\/health-advice\/?p=18995"},"modified":"2026-06-24T09:59:36","modified_gmt":"2026-06-24T09:59:36","slug":"switching-to-wegovy-pill","status":"publish","type":"post","link":"https:\/\/www.simpleonlinepharmacy.co.uk\/health-advice\/weight-loss\/wegovy-pill\/switching-to-wegovy-pill\/","title":{"rendered":"Switching to the Wegovy Pill: What You Need to Know"},"content":{"rendered":"\n

Can I switch to the Wegovy pill from another GLP-1 medication?<\/h2>\n\n\n\n

Yes, you can switch from another GLP-1 medicine to the Wegovy pill<\/a>, but only with a prescriber guiding the change.<\/strong><\/p>\n\n\n\n

The Medicines and Healthcare products Regulatory Agency (MHRA) licenses medicines in the UK. They approved the Wegovy pill<\/a> on 11 June 2026. The MHRA’s 2025 GLP-1 switching guidance<\/a> gives a plain instruction \u2014 speak to a healthcare professional first.<\/p>\n\n\n\n

Doing it alone carries a real cost. Switching without advice can increase the risk of side effects or reduce the new treatment’s effectiveness. GLP-1 medicines vary in strength and dosing rules, so the move is rarely like-for-like.<\/p>\n\n\n\n

UK prescribers can now offer the Wegovy pill. NHS access requires an extra step on top of MHRA approval, so private prescriptions will likely come first. Switching from a weight loss injection to a pill<\/a> will likely follow the similar principles across the GLP-1 class. <\/p>\n\n\n\n

Why do people switch to the Wegovy pill?<\/h2>\n\n\n\n

People consider the Wegovy pill mainly to escape weekly injections or to manage cost. A smaller group wants to keep the cardiovascular protection that semaglutide brings.<\/strong> Needle anxiety is the biggest driver we hear about. A daily tablet appeals to anyone who would rather not handle a weekly or daily injection, even a small one.<\/p>\n\n\n\n

Cost is the second reason. Eli Lilly raised the UK list price of higher-dose Mounjaro sharply in 2025, with the highest dose climbing by around 170%. For some people, that change alone prompts a fresh look at their weight loss medication.<\/p>\n\n\n\n

Now that the pill is approved, its private price sits close to the Wegovy injection rather than below it. The bigger saving is against Mounjaro at its higher doses, so for someone moving off pricier Mounjaro, the Wegovy pill<\/a> can be the cheaper option. For someone already on Wegovy, the cost barely changes.<\/p>\n\n\n\n

Supply is the other draw. Injectable GLP-1s like Wegovy and Mounjaro ran short across the UK through 2023 and 2024, when a surge in demand for weight loss outstripped production, and some people could not fill their prescriptions. Those shortages have largely eased, but a tablet that does not depend on pen manufacturing could make supply steadier in future.<\/p>\n\n\n\n

The heart protection angle matters for a smaller group. Semaglutide is currently the only weight loss GLP-1 also licensed to lower cardiovascular risk. In the SELECT clinical trial<\/a>, it cut the risk of heart attacks, stroke, or death from heart disease by about a fifth. <\/p>\n\n\n\n

That result came from a study of 17,604 adults. For someone who needs that protection, staying on semaglutide in pill form is appealing.<\/p>\n\n\n\n

The results hold up, and it reassures people considering the move. In the OASIS 4 clinical trial<\/a>, average weight loss on the Wegovy pill was 13.6% over 64 weeks. The placebo group, those given an inactive pill for comparison, lost roughly 2%. <\/p>\n\n\n\n

That average weight loss sits close to the weekly Wegovy 2.4mg injection. Prescribers therefore treat the pill as a serious option for long-term weight management.<\/p>\n\n\n\n

What are the key principles of switching GLP-1 medications?<\/h2>\n\n\n\n

A safe switch depends on how long your current medicine stays in your body, and these timings vary widely.<\/strong> The figure behind this is a drug’s half-life, the time the body takes to clear half of a dose. The number that matters in practice is how long the medicine takes to leave your system completely.<\/p>\n\n\n\n

Medicine (active drug)<\/strong><\/td>Half-life <\/strong><\/td>Time to clear your body <\/strong><\/td>Gap before starting the pill <\/strong><\/td><\/tr>
Saxenda or Nevolat (liraglutide) <\/strong><\/td>~ 13 hours<\/td>About 3 days<\/td>Short: possibly the next day, or within a few days at most <\/td><\/tr>
Wegovy injection (semaglutide) <\/strong><\/td>~ 1 week<\/td>Around 5 weeks<\/td>None needed: it is the same drug, so you start the pill one week after your last injection <\/td><\/tr>
Mounjaro (tirzepatide) <\/strong><\/td>~ 5 days<\/td>About 4-5 weeks<\/td>Start the pill seven days after your last injected dose.<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n

The licence sets one switch in stone: moving from the 2.4mg Wegovy injection to the 25mg pill, with no need to build up again. For other doses and switching from other medicines, our clinical team uses internal switching protocols that match your current injectable dose to the right pill strength.<\/p>\n\n\n\n

Where you start below 25mg, you then build up gradually. The dosing schedule steps up every 30 days, so your body adjusts to each higher dose and side effects remain minimal. A prescriber reviews and approves each switch, and can start you lower if side effects were a problem before.<\/p>\n\n\n\t\t

\n\t\t\t\t
\n\t\t
\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t
Wegovy Pill<\/span><\/span><\/div><\/div>\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t
\u00a330 off<\/b> oral GLP-1 pills<\/span><\/div>s<\/div>\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t

Start Now<\/h2>\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t<\/i>\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/a>\n\t\t\t\t<\/div>\n\t\t
\n\t\t\t\t\t
\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\n\n\n\n

How do I transition from the Wegovy injection to the pill?<\/h2>\n\n\n\n

Switching from Wegovy injection to the pill<\/strong> is<\/strong> straightforward. Both forms of Wegovy work through the same active ingredient, semaglutide.<\/strong> Wegovy is the only GLP-1 switch currently with manufacturer guidance built into the product licence. Instructions are clear \u2014 one week after your last 2.4mg injection, you start the 25mg tablet once a day.<\/p>\n\n\n\n

If you are not yet at the 2.4mg Wegovy injection maintenance dose, our clinical team uses a simple chart to match your current injection dose to the right pill dose. <\/p>\n\n\n\n

Wegovy injection dose<\/strong><\/td>Wegovy pill dose<\/strong><\/td><\/tr>
7.2mg, 2.4mg or 1.7mg<\/td>25mg<\/td><\/tr>
1mg or 0.5mg<\/td>9mg<\/td><\/tr>
0.25mg<\/td>4mg<\/td><\/tr>
–<\/td>1.5mg<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n

The timing is the same whichever dose you are on:<\/p>\n\n\n\n